FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1921211000001104: Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25466101000001111 Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58154601000001116 Zantac 150mg/10ml syrup (GlaxoSmithKline UK Ltd) 300 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Is a Ranitidine 75mg/5ml oral solution sugar free 300 ml true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Is pack of Zantac 150mg/10ml syrup (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has manufactured dose form Conventional release oral syrup false Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has AMP Zantac 150mg/10ml syrup (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zantac 150mg/10ml syrup (GlaxoSmithKline) 300 ml Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start